December 11, 2020
Published by pvreporter at December 11, 2020
Categories
by Lou Ann Donovan When you are living with a myeloproliferative neoplasm (MPN), fatigue is the most frequent symptom discussed among fellow patients. One minute you […]
November 2, 2020
Published by pvreporter at November 2, 2020
Categories
by Lou Ann Donovan Are you searching for an MPN clinical trial and wondering what all these acronyms and abbreviations listed in the trial study details […]
October 8, 2020
Published by David Wallace at October 8, 2020
Categories
What are Clinical Trials? by Lou Ann Donovan Clinical trials also called interventional clinical studies involve research using participants. Through clinical trials, doctors find new ways […]
September 21, 2020
Published by pvreporter at September 21, 2020
Categories
MPN Cancer Connection and PV Reporter are partnering with the Cleveland Clinic 4th Angel Mentoring Program to better serve the needs of our growing community seeking […]
September 17, 2020
Published by pvreporter at September 17, 2020
Categories
As a small organization with limited resources, our goal is providing “easy access” to a growing network of organizations that provide services to our community. Patients […]
September 10, 2020
Published by pvreporter at September 10, 2020
Categories
10 Year Anniversary – Blood Cancer Awareness Month 2020 by Lou Ann Donovan National Blood Cancer Awareness Month was designated in September 2010 by the U.S. […]
August 24, 2020
Published by pvreporter at August 24, 2020
Categories
Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer’s disease: evidences and perspectives Hans C. Hasselbalch, Vibe Skov, Lasse Kjær, Torben L. Sørensen, Christina Ellervik & Troels Wienecke […]
June 19, 2020
Published by pvreporter at June 19, 2020
Categories
by Lou Ann Donovan As states begin to reopen businesses and stay at home orders become less restrictive, people are starting to venture out in public […]
May 20, 2020
Published by pvreporter at May 20, 2020
Categories
What is Telehealth? by Lou Ann Donovan Telehealth, also known as Telemedicine or Virtual Care, are broad terms covering all the ways healthcare providers remotely interact […]
January 20, 2020
Published by pvreporter at January 20, 2020
Categories
Authors: Morten Orebo Holmström, Sabrina Cordua, Vibe Skov, Lasse Kjær, Niels Pallisgaard, Christina Ellervik, Hans Carl Hasselbalch, Mads Hald Andersen Evidence of immune elimination, immuno-editing and […]
December 27, 2019
Published by pvreporter at December 27, 2019
Categories
Improving the next generation of drugs through patient-centric design for clinical trials by Dr. Richard Ghalie (Senior VP for Clinical Development at MEI Pharma) When a […]
July 17, 2019
Published by pvreporter at July 17, 2019
Categories
Open Access Article – Petiti J, Rosso V, Lo Iacono M, et al. Curcumin induces apoptosis in JAK2‐mutated cells by the inhibition of JAK2/STAT and mTORC1 […]
June 10, 2019
Published by pvreporter at June 10, 2019
Slower walking pace linked to a higher likelihood of death and hospital visits; Researchers say gait speed should be used along with other vital signs to […]
March 27, 2019
Published by pvreporter at March 27, 2019
Categories
by Scott Sanders (guest author) A cancer diagnosis is devastating but it isn’t a death sentence (in most cases). Myeloproliferative Neoplasms, MPNs, are treatable and with […]
March 14, 2019
Published by pvreporter at March 14, 2019
Categories
Nationwide Population-based survey in Denmark Objective: We sought to determine the prevalence and severity of anxiety and depression among patients with Philadelphia-negative myeloproliferative neoplasms (MPNs) and […]
February 1, 2019
Dr. Verstovsek on Benefit of Ruxolitinib Treatment in PV Srdan Verstovsek, MD, PhD, director of the Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms at […]
January 19, 2019
Published by pvreporter at January 19, 2019
Categories
MPN Patient Advocate Lou Ann Donovan lives in Olathe, Kansas, a suburb of the Greater Kansas City area. She recently retired in the Fall of 2019 […]
December 21, 2018
by David Wallace MPN Cancer Connection is very pleased to announce a new partnership with the PAN Foundation. Myeloproliferative Neoplasm (MPN) patients may be eligible for […]
August 7, 2018
The largest ever study of its type is the first to definitively show an increased risk of blood cancers in relatives of patients. A team […]
July 16, 2018
Published by mpncancer at July 16, 2018
Categories
Brilliant work by Nathalie Cook lobbying the Australian Government for access to affordable drugs for Cancer Patients Inspiring, tenacious and rewarding work that will benefit the […]
April 9, 2018
Published by mpncancer at April 9, 2018
Categories
Publisher’s Note: My source at the American Society of Hematology (ASH) informed me that “initially MPNs aren’t going to be a primary focus, however, we expect […]
March 9, 2018
Metformin demonstrates antileukemic activity and may have clinical implications for the treatment of myeloproliferative neoplasms (MPN) in combination with ruxolitinib, according to a study published in Cell Death & […]
February 22, 2018
Published by mpncancer at February 22, 2018
Categories
AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE Researchers have discovered how some of the blood cancers known as myeloproliferative neoplasms (MPNs) evade the immune system. Their […]
February 1, 2018
Published by mpncancer at February 1, 2018
Categories
Imago BioSciences, a clinical-stage pharmaceutical company developing novel therapies for hematological and inflammatory diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted their […]
January 8, 2018
Published by mpncancer at January 8, 2018
Categories
Celgene Corporation (NASDAQ:CELG) and Impact Biomedicines today announced the signing of a definitive agreement in which Celgene will acquire Impact Biomedicines, which is developing fedratinib for […]
December 27, 2017
The investigational Nutlin family antagonist idasanutlin demonstrated significant activity and was well tolerated after multiple cycles of exposure in patients with refractory polycythemia vera (PV). Data […]
December 1, 2017
Published by mpncancer at December 1, 2017
Categories
A Few Simple Criteria If your doc has never been to the ASH (American Society of Hematology) conference, the largest hematology convention in the world and […]
June 29, 2017
Published by mpncancer at June 29, 2017
Categories
This abstract is provided by Mads Emil Bjorn & Hans Carl Hasselbalch – Department of Hematology, Region Zealand, Roskilde, Denmark Abstract Introduction: The therapeutic landscape of […]
June 15, 2017
Published by mpncancer at June 15, 2017
Categories
UT (University of Texas) San Antonio makes Dr. Ruben Mesa head of their Cancer Center Dr Ruben Mesa, one of the leading MPN Specialist in the […]
June 5, 2017
Published by David Wallace at June 5, 2017
Categories
Abstract Myeloproliferative neoplasm cells recruit Gli1 positive mesenchymal stromal cells to transdifferentiate into fibrosis-causing myofibroblasts, a process that can be inhibited by a Gli inhibitor. Bone […]
April 28, 2017
Published by David Wallace at April 28, 2017
Understanding Polycythemia Vera (PV), A Rare Blood Cancer Behind the Mystery, Polycythemia Vera Every year, millions of patients, families and caregivers are impacted by cancer in […]
January 29, 2017
Published by mpncancer at January 29, 2017
Categories
A Solid Summary on the Latest MPN Research in 2017 Drs. Joseph R. Mikhael and Ruben A. Mesa analyze and discuss pertinent clinical studies and late […]
January 2, 2017
Published by mpncancer at January 2, 2017
Categories
Long Term Exposure to Radiation puts you at higher risk for MPN The Savannah River Site is on a list of qualified places for Special Exposure […]
December 21, 2016
A survey is being conducted to learn more about the most common symptoms experienced by ET patients, and how these symptoms affect the lives of patients. […]
October 18, 2016
Published by mpncancer at October 18, 2016
Categories
New Leukemia Research in Phase I/IIa Clinical Trial Biosight, an Israeli pharmaceutical development company that is working on a cure for leukemia, this week closed an […]
September 21, 2016
Published by mpncancer at September 21, 2016
Categories
[contentcards url=”http://www.oncologynurseadvisor.com/leukemia/factors-associated-with-hearing-loss-in-pv-pinpointed/article/523647/” target=”_blank”] “Researchers found that the mean hemoglobin and hematocrit levels of the polycythemia vera group were 16.7 g/dL and 50.4%, respectively, vs 13.4 g/dL […]
September 20, 2016
Published by mpncancer at September 20, 2016
Categories
Key points The novel IFNα-2b AOP2014 administered once every two weeks (or once a month) has low toxicity and induces high and sustained response rates in […]
August 30, 2016
August 28, 2016
J Korean Med Sci. 2016 Oct;31(10):1579-1585. English. Published online Jul 22, 2016. http://dx.doi.org/10.3346/jkms.2016.31.10.1579 © 2016 The Korean Academy of Medical Sciences. Incidence, Survival and Prevalence Statistics of […]
August 16, 2016
Published by mpncancer at August 16, 2016
Categories
Scientists have devised a way to destroy blood stem cells in mice without using chemotherapy or radiotherapy, both of which have toxic side effects. Blood stem […]